User:Hugues Abriel: Difference between revisions
Jump to navigation
Jump to search
imported>Caesar Schinas m (Bot: Inactive Editor, per CZ:Editorial Council Resolution 0012) |
No edit summary |
||
| Line 1: | Line 1: | ||
{{AccountNotLive}} | |||
Hugues Abriel has been trained both as a life-science scientist and medical doctor (MD PhD), in Switzerland. After two years spent doing clinical work with patients, he is involved since ten years in research projects aiming at elucidating the roles of ion channels in human diseases (channelopathies), with a special emphasis on cardiac arrhythmias. He is now an assistant Professor (Swiss National Science Foundation Professor) at the University of Lausanne, Switzerland, Department of pharmacology and toxicology and service of cardiology, where he leads a research group. | Hugues Abriel has been trained both as a life-science scientist and medical doctor (MD PhD), in Switzerland. After two years spent doing clinical work with patients, he is involved since ten years in research projects aiming at elucidating the roles of ion channels in human diseases (channelopathies), with a special emphasis on cardiac arrhythmias. He is now an assistant Professor (Swiss National Science Foundation Professor) at the University of Lausanne, Switzerland, Department of pharmacology and toxicology and service of cardiology, where he leads a research group. | ||
Latest revision as of 02:58, 22 November 2023
The account of this former contributor was not re-activated after the server upgrade of March 2022.
Hugues Abriel has been trained both as a life-science scientist and medical doctor (MD PhD), in Switzerland. After two years spent doing clinical work with patients, he is involved since ten years in research projects aiming at elucidating the roles of ion channels in human diseases (channelopathies), with a special emphasis on cardiac arrhythmias. He is now an assistant Professor (Swiss National Science Foundation Professor) at the University of Lausanne, Switzerland, Department of pharmacology and toxicology and service of cardiology, where he leads a research group.